Xu-Bao Shi

1.2k total citations
15 papers, 1.0k citations indexed

About

Xu-Bao Shi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xu-Bao Shi has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xu-Bao Shi's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (5 papers). Xu-Bao Shi is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (5 papers). Xu-Bao Shi collaborates with scholars based in United States, Taiwan and India. Xu-Bao Shi's co-authors include Ralph W. deVere White, Clifford G. Tepper, Hsing-Jien Kung, Ai-Hong Ma, Lingru Xue, Christopher P. Evans, Joy C. Yang, Xu Ma, Jianjun Zhao and Ruth L. Vinall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Xu-Bao Shi

15 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xu-Bao Shi United States	13	814	737	174	101	66	15	1.0k
Anna Aakula Finland	9	616 0.8×	462 0.6×	129 0.7×	71 0.7×	43 0.7×	11	733
Fujun Zhao China	14	442 0.5×	243 0.3×	153 0.9×	97 1.0×	59 0.9×	38	683
Maria A. Svensson Sweden	14	390 0.5×	234 0.3×	341 2.0×	105 1.0×	61 0.9×	18	629
Wai Kei Kwok Hong Kong	6	504 0.6×	230 0.3×	124 0.7×	279 2.8×	46 0.7×	6	702
Zandra Hagman Sweden	9	615 0.8×	571 0.8×	194 1.1×	44 0.4×	31 0.5×	11	801
Suhaida A. Selamat United States	6	518 0.6×	242 0.3×	204 1.2×	145 1.4×	128 1.9×	7	715
Hyung Seok Kim South Korea	17	701 0.9×	395 0.5×	152 0.9×	145 1.4×	29 0.4×	29	900
Jue‐Yu Zhou China	15	426 0.5×	278 0.4×	54 0.3×	110 1.1×	34 0.5×	42	591
Maira M. Pires United States	8	409 0.5×	229 0.3×	290 1.7×	145 1.4×	77 1.2×	11	621
Enhua Wang China	16	651 0.8×	614 0.8×	73 0.4×	154 1.5×	29 0.4×	26	867

Countries citing papers authored by Xu-Bao Shi

Since Specialization

Citations

This map shows the geographic impact of Xu-Bao Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu-Bao Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu-Bao Shi more than expected).

Fields of papers citing papers by Xu-Bao Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu-Bao Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu-Bao Shi. The network helps show where Xu-Bao Shi may publish in the future.

Co-authorship network of co-authors of Xu-Bao Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xu-Bao Shi. A scholar is included among the top collaborators of Xu-Bao Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu-Bao Shi. Xu-Bao Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shi, Xu-Bao, Ai-Hong Ma, Lingru Xue, et al.. (2015). miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Research. 75(24). 5309–5317. 61 indexed citations

Amir, Sumaira, Ai-Hong Ma, Xu-Bao Shi, et al.. (2013). Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer. PLoS ONE. 8(4). e61064–e61064. 77 indexed citations

Nadiminty, Nagalakshmi, Ramakumar Tummala, Wei Lou, et al.. (2012). MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth. PLoS ONE. 7(3). e32832–e32832. 147 indexed citations

Shi, Xu-Bao, et al.. (2011). Influence of Short Polyglutamine Tracts and p160 Coactivators on the Transactivation of the Androgen Receptor. Cancer Biotherapy and Radiopharmaceuticals. 26(2). 191–201. 3 indexed citations

White, Ralph W. deVere, Ruth L. Vinall, Clifford G. Tepper, & Xu-Bao Shi. (2009). MicroRNAs and their potential for translation in prostate cancer. Urologic Oncology Seminars and Original Investigations. 27(3). 307–311. 63 indexed citations

Shi, Xu-Bao, Clifford G. Tepper, & Ralph W. deVere White. (2008). Cancerous miRNAs and their regulation. Cell Cycle. 7(11). 1529–1538. 94 indexed citations

Shi, Xu-Bao, Lingru Xue, Joy C. Yang, et al.. (2007). An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proceedings of the National Academy of Sciences. 104(50). 19983–19988. 390 indexed citations

You, Zongbing, Xu-Bao Shi, Grayson DuRaine, et al.. (2006). Interleukin-17 Receptor-Like Gene Is a Novel Antiapoptotic Gene Highly Expressed in Androgen-Independent Prostate Cancer. Cancer Research. 66(1). 175–183. 35 indexed citations

Zou, June X., Zhenyu Zhong, Xu-Bao Shi, et al.. (2006). ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. The Prostate. 66(14). 1474–1486. 36 indexed citations

10.

Ma, Ai-Hong, Liang Xia, Sonal J. Desai, et al.. (2006). Male Germ Cell–Associated Kinase, a Male-Specific Kinase Regulated by Androgen, Is a Coactivator of Androgen Receptor in Prostate Cancer Cells. Cancer Research. 66(17). 8439–8447. 27 indexed citations

11.

Tepper, Clifford G., Jeffrey P. Gregg, Xu-Bao Shi, et al.. (2005). Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. The Prostate. 65(4). 375–389. 30 indexed citations

12.

Scott, Susan, Roger Higdon, Laurel Beckett, et al.. (2002). BCL2 Antisense Reduces Prostate Cancer Cell Survival Following Irradiation. Cancer Biotherapy and Radiopharmaceuticals. 17(6). 647–656. 17 indexed citations

13.

Shi, Xu-Bao, Ralph A. Highshaw, Arline D. Deitch, et al.. (2002). Application of a Yeast Assay to Detect Functional p53 Mutations in Archival Prostate Cancer Tissue. Cancer Biotherapy and Radiopharmaceuticals. 17(6). 657–664. 6 indexed citations

14.

White, Ralph W. deVere, Arline D. Deitch, Paul H. Gumerlock, & Xu-Bao Shi. (1999). Use of a yeast assay to detect functional alterations inp53 in prostate cancer: Review and future directions. The Prostate. 41(2). 134–142. 12 indexed citations

15.

OʼDonnell, Robert T., Sally J. DeNardo, Xu-Bao Shi, et al.. (1998). L6 monoclonal antibody binds prostate cancer. The Prostate. 37(2). 91–97. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact